nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP2D6—Niacin—atherosclerosis	0.0472	0.108	CbGbCtD
Mefloquine—ABCB1—Ezetimibe—atherosclerosis	0.0426	0.0972	CbGbCtD
Mefloquine—ABCB1—Simvastatin—atherosclerosis	0.0396	0.0903	CbGbCtD
Mefloquine—ABCB1—Pravastatin—atherosclerosis	0.0388	0.0884	CbGbCtD
Mefloquine—ABCB1—Lovastatin—atherosclerosis	0.0388	0.0884	CbGbCtD
Mefloquine—CYP2D6—Simvastatin—atherosclerosis	0.0373	0.0851	CbGbCtD
Mefloquine—CYP2D6—Lovastatin—atherosclerosis	0.0365	0.0833	CbGbCtD
Mefloquine—CYP2D6—Pravastatin—atherosclerosis	0.0365	0.0833	CbGbCtD
Mefloquine—CYP3A4—Ezetimibe—atherosclerosis	0.0255	0.0582	CbGbCtD
Mefloquine—CYP3A4—Rosuvastatin—atherosclerosis	0.0255	0.0582	CbGbCtD
Mefloquine—CYP3A4—Simvastatin—atherosclerosis	0.0237	0.0541	CbGbCtD
Mefloquine—CYP3A4—Pravastatin—atherosclerosis	0.0232	0.053	CbGbCtD
Mefloquine—CYP3A4—Lovastatin—atherosclerosis	0.0232	0.053	CbGbCtD
Mefloquine—HBA2—leg—atherosclerosis	0.0157	0.124	CbGeAlD
Mefloquine—HBA1—hindlimb—atherosclerosis	0.0153	0.121	CbGeAlD
Mefloquine—HBA2—hindlimb—atherosclerosis	0.0141	0.111	CbGeAlD
Mefloquine—HBA1—appendage—atherosclerosis	0.0131	0.104	CbGeAlD
Mefloquine—HBA2—appendage—atherosclerosis	0.0121	0.095	CbGeAlD
Mefloquine—HBA2—artery—atherosclerosis	0.00862	0.0679	CbGeAlD
Mefloquine—HBA2—endothelium—atherosclerosis	0.00728	0.0574	CbGeAlD
Mefloquine—HBA2—blood vessel—atherosclerosis	0.00672	0.0529	CbGeAlD
Mefloquine—HBA1—connective tissue—atherosclerosis	0.00375	0.0295	CbGeAlD
Mefloquine—HBA2—connective tissue—atherosclerosis	0.00344	0.0271	CbGeAlD
Mefloquine—HBA1—cardiovascular system—atherosclerosis	0.00326	0.0257	CbGeAlD
Mefloquine—HBA2—cardiovascular system—atherosclerosis	0.003	0.0236	CbGeAlD
Mefloquine—HBA1—adipose tissue—atherosclerosis	0.00288	0.0227	CbGeAlD
Mefloquine—HBA2—adipose tissue—atherosclerosis	0.00264	0.0208	CbGeAlD
Mefloquine—HBA1—liver—atherosclerosis	0.00202	0.0159	CbGeAlD
Mefloquine—HBA2—liver—atherosclerosis	0.00185	0.0146	CbGeAlD
Mefloquine—ADORA2A—cardiovascular system—atherosclerosis	0.00156	0.0123	CbGeAlD
Mefloquine—ADORA1—cardiovascular system—atherosclerosis	0.00135	0.0106	CbGeAlD
Mefloquine—ADORA1—adipose tissue—atherosclerosis	0.00119	0.00935	CbGeAlD
Mefloquine—CYP19A1—connective tissue—atherosclerosis	0.00105	0.00827	CbGeAlD
Mefloquine—ADORA2A—liver—atherosclerosis	0.000964	0.0076	CbGeAlD
Mefloquine—CYP19A1—adipose tissue—atherosclerosis	0.000805	0.00634	CbGeAlD
Mefloquine—ABCB1—blood vessel—atherosclerosis	0.000703	0.00553	CbGeAlD
Mefloquine—BCHE—cardiovascular system—atherosclerosis	0.000658	0.00518	CbGeAlD
Mefloquine—Flushing—Lovastatin—atherosclerosis	0.000623	0.00283	CcSEcCtD
Mefloquine—Erythema multiforme—Ezetimibe—atherosclerosis	0.000622	0.00283	CcSEcCtD
Mefloquine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00062	0.00282	CcSEcCtD
Mefloquine—Sweating—Niacin—atherosclerosis	0.000616	0.0028	CcSEcCtD
Mefloquine—Flushing—Ezetimibe—atherosclerosis	0.000611	0.00278	CcSEcCtD
Mefloquine—Chills—Lovastatin—atherosclerosis	0.000602	0.00274	CcSEcCtD
Mefloquine—Angiopathy—Ezetimibe—atherosclerosis	0.000597	0.00272	CcSEcCtD
Mefloquine—Erythema multiforme—Simvastatin—atherosclerosis	0.000594	0.0027	CcSEcCtD
Mefloquine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000593	0.0027	CcSEcCtD
Mefloquine—Alopecia—Lovastatin—atherosclerosis	0.000593	0.0027	CcSEcCtD
Mefloquine—Arthralgia—Rosuvastatin—atherosclerosis	0.000587	0.00267	CcSEcCtD
Mefloquine—Myalgia—Rosuvastatin—atherosclerosis	0.000587	0.00267	CcSEcCtD
Mefloquine—Flushing—Simvastatin—atherosclerosis	0.000583	0.00265	CcSEcCtD
Mefloquine—Alopecia—Ezetimibe—atherosclerosis	0.000582	0.00265	CcSEcCtD
Mefloquine—BCHE—adipose tissue—atherosclerosis	0.00058	0.00457	CbGeAlD
Mefloquine—Mental disorder—Ezetimibe—atherosclerosis	0.000577	0.00262	CcSEcCtD
Mefloquine—Erythema—Ezetimibe—atherosclerosis	0.000573	0.00261	CcSEcCtD
Mefloquine—Malnutrition—Ezetimibe—atherosclerosis	0.000573	0.00261	CcSEcCtD
Mefloquine—Confusional state—Rosuvastatin—atherosclerosis	0.000567	0.00258	CcSEcCtD
Mefloquine—CYP19A1—liver—atherosclerosis	0.000565	0.00445	CbGeAlD
Mefloquine—Chills—Simvastatin—atherosclerosis	0.000563	0.00256	CcSEcCtD
Mefloquine—Muscle spasms—Lovastatin—atherosclerosis	0.000562	0.00255	CcSEcCtD
Mefloquine—Visual impairment—Niacin—atherosclerosis	0.000555	0.00253	CcSEcCtD
Mefloquine—Alopecia—Simvastatin—atherosclerosis	0.000555	0.00252	CcSEcCtD
Mefloquine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000552	0.00251	CcSEcCtD
Mefloquine—Muscle spasms—Ezetimibe—atherosclerosis	0.000551	0.00251	CcSEcCtD
Mefloquine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000551	0.00251	CcSEcCtD
Mefloquine—Vision blurred—Lovastatin—atherosclerosis	0.000551	0.0025	CcSEcCtD
Mefloquine—Mental disorder—Simvastatin—atherosclerosis	0.00055	0.0025	CcSEcCtD
Mefloquine—Tremor—Lovastatin—atherosclerosis	0.000547	0.00249	CcSEcCtD
Mefloquine—Visual impairment—Pravastatin—atherosclerosis	0.000547	0.00249	CcSEcCtD
Mefloquine—Erythema—Simvastatin—atherosclerosis	0.000546	0.00249	CcSEcCtD
Mefloquine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000542	0.00247	CcSEcCtD
Mefloquine—Eye disorder—Niacin—atherosclerosis	0.000539	0.00245	CcSEcCtD
Mefloquine—Tinnitus—Niacin—atherosclerosis	0.000537	0.00244	CcSEcCtD
Mefloquine—Erythema multiforme—Pravastatin—atherosclerosis	0.000537	0.00244	CcSEcCtD
Mefloquine—Flushing—Niacin—atherosclerosis	0.000535	0.00243	CcSEcCtD
Mefloquine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000532	0.00242	CcSEcCtD
Mefloquine—Tinnitus—Pravastatin—atherosclerosis	0.000529	0.00241	CcSEcCtD
Mefloquine—Malaise—Lovastatin—atherosclerosis	0.000527	0.0024	CcSEcCtD
Mefloquine—Cardiac disorder—Pravastatin—atherosclerosis	0.000527	0.0024	CcSEcCtD
Mefloquine—Flushing—Pravastatin—atherosclerosis	0.000527	0.0024	CcSEcCtD
Mefloquine—Muscle spasms—Simvastatin—atherosclerosis	0.000525	0.00239	CcSEcCtD
Mefloquine—Vertigo—Lovastatin—atherosclerosis	0.000525	0.00239	CcSEcCtD
Mefloquine—Angiopathy—Niacin—atherosclerosis	0.000523	0.00238	CcSEcCtD
Mefloquine—Leukopenia—Lovastatin—atherosclerosis	0.000523	0.00238	CcSEcCtD
Mefloquine—Chills—Niacin—atherosclerosis	0.000517	0.00235	CcSEcCtD
Mefloquine—Malaise—Ezetimibe—atherosclerosis	0.000517	0.00235	CcSEcCtD
Mefloquine—Vision blurred—Simvastatin—atherosclerosis	0.000515	0.00234	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000513	0.00233	CcSEcCtD
Mefloquine—Tremor—Simvastatin—atherosclerosis	0.000512	0.00233	CcSEcCtD
Mefloquine—Alopecia—Niacin—atherosclerosis	0.000509	0.00232	CcSEcCtD
Mefloquine—Chills—Pravastatin—atherosclerosis	0.000509	0.00232	CcSEcCtD
Mefloquine—Insomnia—Rosuvastatin—atherosclerosis	0.000509	0.00231	CcSEcCtD
Mefloquine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000507	0.00231	CcSEcCtD
Mefloquine—Palpitations—Ezetimibe—atherosclerosis	0.000506	0.0023	CcSEcCtD
Mefloquine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000505	0.0023	CcSEcCtD
Mefloquine—Erythema—Niacin—atherosclerosis	0.000502	0.00228	CcSEcCtD
Mefloquine—Malnutrition—Niacin—atherosclerosis	0.000502	0.00228	CcSEcCtD
Mefloquine—Alopecia—Pravastatin—atherosclerosis	0.000501	0.00228	CcSEcCtD
Mefloquine—Myalgia—Lovastatin—atherosclerosis	0.000497	0.00226	CcSEcCtD
Mefloquine—Arthralgia—Lovastatin—atherosclerosis	0.000497	0.00226	CcSEcCtD
Mefloquine—Chest pain—Lovastatin—atherosclerosis	0.000497	0.00226	CcSEcCtD
Mefloquine—Anxiety—Lovastatin—atherosclerosis	0.000496	0.00225	CcSEcCtD
Mefloquine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000495	0.00225	CcSEcCtD
Mefloquine—Hypertension—Ezetimibe—atherosclerosis	0.000495	0.00225	CcSEcCtD
Mefloquine—Malaise—Simvastatin—atherosclerosis	0.000493	0.00224	CcSEcCtD
Mefloquine—Discomfort—Lovastatin—atherosclerosis	0.000491	0.00224	CcSEcCtD
Mefloquine—Vertigo—Simvastatin—atherosclerosis	0.000491	0.00223	CcSEcCtD
Mefloquine—Leukopenia—Simvastatin—atherosclerosis	0.000489	0.00222	CcSEcCtD
Mefloquine—Chest pain—Ezetimibe—atherosclerosis	0.000488	0.00222	CcSEcCtD
Mefloquine—Arthralgia—Ezetimibe—atherosclerosis	0.000488	0.00222	CcSEcCtD
Mefloquine—Myalgia—Ezetimibe—atherosclerosis	0.000488	0.00222	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000484	0.0022	CcSEcCtD
Mefloquine—Muscle spasms—Niacin—atherosclerosis	0.000482	0.00219	CcSEcCtD
Mefloquine—Discomfort—Ezetimibe—atherosclerosis	0.000482	0.00219	CcSEcCtD
Mefloquine—Confusional state—Lovastatin—atherosclerosis	0.000481	0.00219	CcSEcCtD
Mefloquine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000477	0.00217	CcSEcCtD
Mefloquine—Muscle spasms—Pravastatin—atherosclerosis	0.000475	0.00216	CcSEcCtD
Mefloquine—Vision blurred—Niacin—atherosclerosis	0.000473	0.00215	CcSEcCtD
Mefloquine—Confusional state—Ezetimibe—atherosclerosis	0.000472	0.00214	CcSEcCtD
Mefloquine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000468	0.00213	CcSEcCtD
Mefloquine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000467	0.00212	CcSEcCtD
Mefloquine—Vision blurred—Pravastatin—atherosclerosis	0.000466	0.00212	CcSEcCtD
Mefloquine—Arthralgia—Simvastatin—atherosclerosis	0.000465	0.00212	CcSEcCtD
Mefloquine—Chest pain—Simvastatin—atherosclerosis	0.000465	0.00212	CcSEcCtD
Mefloquine—Myalgia—Simvastatin—atherosclerosis	0.000465	0.00212	CcSEcCtD
Mefloquine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000464	0.00211	CcSEcCtD
Mefloquine—Anxiety—Simvastatin—atherosclerosis	0.000464	0.00211	CcSEcCtD
Mefloquine—Tremor—Pravastatin—atherosclerosis	0.000463	0.00211	CcSEcCtD
Mefloquine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00046	0.00209	CcSEcCtD
Mefloquine—Discomfort—Simvastatin—atherosclerosis	0.00046	0.00209	CcSEcCtD
Mefloquine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000459	0.00209	CcSEcCtD
Mefloquine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000458	0.00208	CcSEcCtD
Mefloquine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000458	0.00208	CcSEcCtD
Mefloquine—Skin disorder—Ezetimibe—atherosclerosis	0.000454	0.00207	CcSEcCtD
Mefloquine—Vertigo—Niacin—atherosclerosis	0.000451	0.00205	CcSEcCtD
Mefloquine—Syncope—Niacin—atherosclerosis	0.00045	0.00205	CcSEcCtD
Mefloquine—Confusional state—Simvastatin—atherosclerosis	0.00045	0.00205	CcSEcCtD
Mefloquine—Leukopenia—Niacin—atherosclerosis	0.000449	0.00204	CcSEcCtD
Mefloquine—Urticaria—Rosuvastatin—atherosclerosis	0.000447	0.00203	CcSEcCtD
Mefloquine—Oedema—Simvastatin—atherosclerosis	0.000446	0.00203	CcSEcCtD
Mefloquine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000446	0.00203	CcSEcCtD
Mefloquine—Malaise—Pravastatin—atherosclerosis	0.000446	0.00203	CcSEcCtD
Mefloquine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000445	0.00202	CcSEcCtD
Mefloquine—Vertigo—Pravastatin—atherosclerosis	0.000444	0.00202	CcSEcCtD
Mefloquine—Palpitations—Niacin—atherosclerosis	0.000443	0.00202	CcSEcCtD
Mefloquine—Leukopenia—Pravastatin—atherosclerosis	0.000442	0.00201	CcSEcCtD
Mefloquine—Loss of consciousness—Niacin—atherosclerosis	0.000441	0.00201	CcSEcCtD
Mefloquine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000437	0.00199	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000434	0.00198	CcSEcCtD
Mefloquine—Insomnia—Lovastatin—atherosclerosis	0.000431	0.00196	CcSEcCtD
Mefloquine—Paraesthesia—Lovastatin—atherosclerosis	0.000428	0.00195	CcSEcCtD
Mefloquine—Arthralgia—Niacin—atherosclerosis	0.000427	0.00194	CcSEcCtD
Mefloquine—Myalgia—Niacin—atherosclerosis	0.000427	0.00194	CcSEcCtD
Mefloquine—Hypertension—Pravastatin—atherosclerosis	0.000427	0.00194	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000426	0.00194	CcSEcCtD
Mefloquine—Dyspnoea—Lovastatin—atherosclerosis	0.000425	0.00193	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000424	0.00193	CcSEcCtD
Mefloquine—Insomnia—Ezetimibe—atherosclerosis	0.000423	0.00192	CcSEcCtD
Mefloquine—Arthralgia—Pravastatin—atherosclerosis	0.000421	0.00191	CcSEcCtD
Mefloquine—Myalgia—Pravastatin—atherosclerosis	0.000421	0.00191	CcSEcCtD
Mefloquine—Chest pain—Pravastatin—atherosclerosis	0.000421	0.00191	CcSEcCtD
Mefloquine—Paraesthesia—Ezetimibe—atherosclerosis	0.00042	0.00191	CcSEcCtD
Mefloquine—Dyspepsia—Lovastatin—atherosclerosis	0.00042	0.00191	CcSEcCtD
Mefloquine—Anxiety—Pravastatin—atherosclerosis	0.000419	0.00191	CcSEcCtD
Mefloquine—Dyspnoea—Ezetimibe—atherosclerosis	0.000417	0.0019	CcSEcCtD
Mefloquine—Discomfort—Pravastatin—atherosclerosis	0.000416	0.00189	CcSEcCtD
Mefloquine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000415	0.00189	CcSEcCtD
Mefloquine—Decreased appetite—Lovastatin—atherosclerosis	0.000414	0.00189	CcSEcCtD
Mefloquine—Dyspepsia—Ezetimibe—atherosclerosis	0.000412	0.00187	CcSEcCtD
Mefloquine—Fatigue—Lovastatin—atherosclerosis	0.000411	0.00187	CcSEcCtD
Mefloquine—Anaphylactic shock—Niacin—atherosclerosis	0.00041	0.00186	CcSEcCtD
Mefloquine—Oedema—Niacin—atherosclerosis	0.00041	0.00186	CcSEcCtD
Mefloquine—BCHE—liver—atherosclerosis	0.000407	0.0032	CbGeAlD
Mefloquine—Confusional state—Pravastatin—atherosclerosis	0.000407	0.00185	CcSEcCtD
Mefloquine—Decreased appetite—Ezetimibe—atherosclerosis	0.000407	0.00185	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000406	0.00185	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000404	0.00184	CcSEcCtD
Mefloquine—Asthenia—Rosuvastatin—atherosclerosis	0.000404	0.00184	CcSEcCtD
Mefloquine—Insomnia—Simvastatin—atherosclerosis	0.000403	0.00183	CcSEcCtD
Mefloquine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000403	0.00183	CcSEcCtD
Mefloquine—Oedema—Pravastatin—atherosclerosis	0.000403	0.00183	CcSEcCtD
Mefloquine—Fatigue—Ezetimibe—atherosclerosis	0.000403	0.00183	CcSEcCtD
Mefloquine—Shock—Niacin—atherosclerosis	0.000403	0.00183	CcSEcCtD
Mefloquine—Paraesthesia—Simvastatin—atherosclerosis	0.0004	0.00182	CcSEcCtD
Mefloquine—Tachycardia—Niacin—atherosclerosis	0.0004	0.00182	CcSEcCtD
Mefloquine—Pruritus—Rosuvastatin—atherosclerosis	0.000398	0.00181	CcSEcCtD
Mefloquine—Skin disorder—Niacin—atherosclerosis	0.000398	0.00181	CcSEcCtD
Mefloquine—Dyspnoea—Simvastatin—atherosclerosis	0.000398	0.00181	CcSEcCtD
Mefloquine—Hyperhidrosis—Niacin—atherosclerosis	0.000396	0.0018	CcSEcCtD
Mefloquine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000395	0.0018	CcSEcCtD
Mefloquine—Feeling abnormal—Lovastatin—atherosclerosis	0.000393	0.00179	CcSEcCtD
Mefloquine—Dyspepsia—Simvastatin—atherosclerosis	0.000393	0.00179	CcSEcCtD
Mefloquine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00039	0.00177	CcSEcCtD
Mefloquine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00039	0.00177	CcSEcCtD
Mefloquine—Decreased appetite—Simvastatin—atherosclerosis	0.000388	0.00176	CcSEcCtD
Mefloquine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000385	0.00175	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000385	0.00175	CcSEcCtD
Mefloquine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000385	0.00175	CcSEcCtD
Mefloquine—Fatigue—Simvastatin—atherosclerosis	0.000384	0.00175	CcSEcCtD
Mefloquine—Hypotension—Niacin—atherosclerosis	0.000383	0.00174	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000382	0.00174	CcSEcCtD
Mefloquine—Urticaria—Lovastatin—atherosclerosis	0.000379	0.00172	CcSEcCtD
Mefloquine—Body temperature increased—Lovastatin—atherosclerosis	0.000377	0.00171	CcSEcCtD
Mefloquine—Abdominal pain—Lovastatin—atherosclerosis	0.000377	0.00171	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000373	0.0017	CcSEcCtD
Mefloquine—Dizziness—Rosuvastatin—atherosclerosis	0.000372	0.00169	CcSEcCtD
Mefloquine—Urticaria—Ezetimibe—atherosclerosis	0.000372	0.00169	CcSEcCtD
Mefloquine—Insomnia—Niacin—atherosclerosis	0.00037	0.00168	CcSEcCtD
Mefloquine—Body temperature increased—Ezetimibe—atherosclerosis	0.00037	0.00168	CcSEcCtD
Mefloquine—Abdominal pain—Ezetimibe—atherosclerosis	0.00037	0.00168	CcSEcCtD
Mefloquine—Paraesthesia—Niacin—atherosclerosis	0.000368	0.00167	CcSEcCtD
Mefloquine—Feeling abnormal—Simvastatin—atherosclerosis	0.000368	0.00167	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000367	0.00167	CcSEcCtD
Mefloquine—Dyspnoea—Niacin—atherosclerosis	0.000365	0.00166	CcSEcCtD
Mefloquine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000365	0.00166	CcSEcCtD
Mefloquine—Insomnia—Pravastatin—atherosclerosis	0.000365	0.00166	CcSEcCtD
Mefloquine—Somnolence—Niacin—atherosclerosis	0.000364	0.00166	CcSEcCtD
Mefloquine—Paraesthesia—Pravastatin—atherosclerosis	0.000362	0.00165	CcSEcCtD
Mefloquine—Dyspepsia—Niacin—atherosclerosis	0.00036	0.00164	CcSEcCtD
Mefloquine—Dyspnoea—Pravastatin—atherosclerosis	0.000359	0.00163	CcSEcCtD
Mefloquine—Decreased appetite—Niacin—atherosclerosis	0.000356	0.00162	CcSEcCtD
Mefloquine—Dyspepsia—Pravastatin—atherosclerosis	0.000355	0.00161	CcSEcCtD
Mefloquine—Rash—Rosuvastatin—atherosclerosis	0.000355	0.00161	CcSEcCtD
Mefloquine—Dermatitis—Rosuvastatin—atherosclerosis	0.000354	0.00161	CcSEcCtD
Mefloquine—Urticaria—Simvastatin—atherosclerosis	0.000354	0.00161	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000354	0.00161	CcSEcCtD
Mefloquine—Abdominal pain—Simvastatin—atherosclerosis	0.000353	0.0016	CcSEcCtD
Mefloquine—Body temperature increased—Simvastatin—atherosclerosis	0.000353	0.0016	CcSEcCtD
Mefloquine—Headache—Rosuvastatin—atherosclerosis	0.000352	0.0016	CcSEcCtD
Mefloquine—Hypersensitivity—Lovastatin—atherosclerosis	0.000351	0.0016	CcSEcCtD
Mefloquine—Decreased appetite—Pravastatin—atherosclerosis	0.00035	0.00159	CcSEcCtD
Mefloquine—Fatigue—Pravastatin—atherosclerosis	0.000348	0.00158	CcSEcCtD
Mefloquine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000345	0.00157	CcSEcCtD
Mefloquine—Asthenia—Lovastatin—atherosclerosis	0.000342	0.00156	CcSEcCtD
Mefloquine—Pruritus—Lovastatin—atherosclerosis	0.000337	0.00153	CcSEcCtD
Mefloquine—Asthenia—Ezetimibe—atherosclerosis	0.000336	0.00153	CcSEcCtD
Mefloquine—Gastrointestinal pain—Niacin—atherosclerosis	0.000335	0.00152	CcSEcCtD
Mefloquine—Nausea—Rosuvastatin—atherosclerosis	0.000334	0.00152	CcSEcCtD
Mefloquine—Feeling abnormal—Pravastatin—atherosclerosis	0.000332	0.00151	CcSEcCtD
Mefloquine—Pruritus—Ezetimibe—atherosclerosis	0.000331	0.0015	CcSEcCtD
Mefloquine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00033	0.0015	CcSEcCtD
Mefloquine—Hypersensitivity—Simvastatin—atherosclerosis	0.000329	0.00149	CcSEcCtD
Mefloquine—Diarrhoea—Lovastatin—atherosclerosis	0.000326	0.00148	CcSEcCtD
Mefloquine—Urticaria—Niacin—atherosclerosis	0.000325	0.00148	CcSEcCtD
Mefloquine—Body temperature increased—Niacin—atherosclerosis	0.000324	0.00147	CcSEcCtD
Mefloquine—Abdominal pain—Niacin—atherosclerosis	0.000324	0.00147	CcSEcCtD
Mefloquine—Urticaria—Pravastatin—atherosclerosis	0.00032	0.00146	CcSEcCtD
Mefloquine—Asthenia—Simvastatin—atherosclerosis	0.00032	0.00146	CcSEcCtD
Mefloquine—Diarrhoea—Ezetimibe—atherosclerosis	0.00032	0.00146	CcSEcCtD
Mefloquine—Abdominal pain—Pravastatin—atherosclerosis	0.000319	0.00145	CcSEcCtD
Mefloquine—Body temperature increased—Pravastatin—atherosclerosis	0.000319	0.00145	CcSEcCtD
Mefloquine—Pruritus—Simvastatin—atherosclerosis	0.000316	0.00144	CcSEcCtD
Mefloquine—Dizziness—Lovastatin—atherosclerosis	0.000315	0.00143	CcSEcCtD
Mefloquine—ABCB1—cardiovascular system—atherosclerosis	0.000313	0.00247	CbGeAlD
Mefloquine—Dizziness—Ezetimibe—atherosclerosis	0.000309	0.00141	CcSEcCtD
Mefloquine—Diarrhoea—Simvastatin—atherosclerosis	0.000305	0.00139	CcSEcCtD
Mefloquine—Vomiting—Lovastatin—atherosclerosis	0.000303	0.00138	CcSEcCtD
Mefloquine—Hypersensitivity—Niacin—atherosclerosis	0.000302	0.00137	CcSEcCtD
Mefloquine—Rash—Lovastatin—atherosclerosis	0.000301	0.00137	CcSEcCtD
Mefloquine—Dermatitis—Lovastatin—atherosclerosis	0.0003	0.00137	CcSEcCtD
Mefloquine—Headache—Lovastatin—atherosclerosis	0.000299	0.00136	CcSEcCtD
Mefloquine—Vomiting—Ezetimibe—atherosclerosis	0.000297	0.00135	CcSEcCtD
Mefloquine—Hypersensitivity—Pravastatin—atherosclerosis	0.000297	0.00135	CcSEcCtD
Mefloquine—Dizziness—Simvastatin—atherosclerosis	0.000295	0.00134	CcSEcCtD
Mefloquine—Rash—Ezetimibe—atherosclerosis	0.000295	0.00134	CcSEcCtD
Mefloquine—Dermatitis—Ezetimibe—atherosclerosis	0.000295	0.00134	CcSEcCtD
Mefloquine—Asthenia—Niacin—atherosclerosis	0.000294	0.00134	CcSEcCtD
Mefloquine—Headache—Ezetimibe—atherosclerosis	0.000293	0.00133	CcSEcCtD
Mefloquine—Pruritus—Niacin—atherosclerosis	0.00029	0.00132	CcSEcCtD
Mefloquine—Asthenia—Pravastatin—atherosclerosis	0.000289	0.00132	CcSEcCtD
Mefloquine—Pruritus—Pravastatin—atherosclerosis	0.000285	0.0013	CcSEcCtD
Mefloquine—Vomiting—Simvastatin—atherosclerosis	0.000284	0.00129	CcSEcCtD
Mefloquine—Nausea—Lovastatin—atherosclerosis	0.000283	0.00129	CcSEcCtD
Mefloquine—Rash—Simvastatin—atherosclerosis	0.000281	0.00128	CcSEcCtD
Mefloquine—Dermatitis—Simvastatin—atherosclerosis	0.000281	0.00128	CcSEcCtD
Mefloquine—Diarrhoea—Niacin—atherosclerosis	0.00028	0.00127	CcSEcCtD
Mefloquine—Headache—Simvastatin—atherosclerosis	0.000279	0.00127	CcSEcCtD
Mefloquine—Nausea—Ezetimibe—atherosclerosis	0.000278	0.00126	CcSEcCtD
Mefloquine—ABCB1—adipose tissue—atherosclerosis	0.000276	0.00218	CbGeAlD
Mefloquine—Diarrhoea—Pravastatin—atherosclerosis	0.000276	0.00125	CcSEcCtD
Mefloquine—CYP3A4—liver—atherosclerosis	0.000274	0.00216	CbGeAlD
Mefloquine—Dizziness—Niacin—atherosclerosis	0.000271	0.00123	CcSEcCtD
Mefloquine—CYP2D6—liver—atherosclerosis	0.000269	0.00212	CbGeAlD
Mefloquine—Dizziness—Pravastatin—atherosclerosis	0.000267	0.00121	CcSEcCtD
Mefloquine—Nausea—Simvastatin—atherosclerosis	0.000265	0.0012	CcSEcCtD
Mefloquine—Vomiting—Niacin—atherosclerosis	0.00026	0.00118	CcSEcCtD
Mefloquine—Rash—Niacin—atherosclerosis	0.000258	0.00117	CcSEcCtD
Mefloquine—Dermatitis—Niacin—atherosclerosis	0.000258	0.00117	CcSEcCtD
Mefloquine—Headache—Niacin—atherosclerosis	0.000257	0.00117	CcSEcCtD
Mefloquine—Vomiting—Pravastatin—atherosclerosis	0.000256	0.00117	CcSEcCtD
Mefloquine—Rash—Pravastatin—atherosclerosis	0.000254	0.00116	CcSEcCtD
Mefloquine—Dermatitis—Pravastatin—atherosclerosis	0.000254	0.00116	CcSEcCtD
Mefloquine—Headache—Pravastatin—atherosclerosis	0.000253	0.00115	CcSEcCtD
Mefloquine—Nausea—Niacin—atherosclerosis	0.000243	0.00111	CcSEcCtD
Mefloquine—Nausea—Pravastatin—atherosclerosis	0.000239	0.00109	CcSEcCtD
Mefloquine—ABCB1—liver—atherosclerosis	0.000194	0.00153	CbGeAlD
Mefloquine—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	1.53e-05	7.13e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDN1—atherosclerosis	1.53e-05	7.11e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.52e-05	7.08e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—F2—atherosclerosis	1.52e-05	7.07e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL5—atherosclerosis	1.51e-05	7.06e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLTP—atherosclerosis	1.51e-05	7.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.5e-05	6.98e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—FABP4—atherosclerosis	1.49e-05	6.92e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LCAT—atherosclerosis	1.49e-05	6.92e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOB—atherosclerosis	1.48e-05	6.9e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LPL—atherosclerosis	1.48e-05	6.9e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA4—atherosclerosis	1.46e-05	6.79e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CG—atherosclerosis	1.45e-05	6.76e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GSTM1—atherosclerosis	1.44e-05	6.72e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PRKCG—atherosclerosis	1.44e-05	6.71e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.44e-05	6.7e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.43e-05	6.67e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—HMOX1—atherosclerosis	1.42e-05	6.62e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.42e-05	6.6e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—LPL—atherosclerosis	1.41e-05	6.59e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.4e-05	6.55e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—atherosclerosis	1.4e-05	6.54e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—atherosclerosis	1.4e-05	6.51e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—MAPK3—atherosclerosis	1.39e-05	6.48e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GPX1—atherosclerosis	1.38e-05	6.43e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—HMOX1—atherosclerosis	1.38e-05	6.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.38e-05	6.42e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.38e-05	6.41e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—INS—atherosclerosis	1.37e-05	6.4e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	1.36e-05	6.36e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOB—atherosclerosis	1.36e-05	6.34e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL2—atherosclerosis	1.35e-05	6.3e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CD36—atherosclerosis	1.34e-05	6.26e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.33e-05	6.21e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOA2—atherosclerosis	1.33e-05	6.21e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.33e-05	6.21e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALOX15—atherosclerosis	1.33e-05	6.21e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IGF1—atherosclerosis	1.33e-05	6.19e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GSTM1—atherosclerosis	1.32e-05	6.17e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.32e-05	6.17e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOB—atherosclerosis	1.32e-05	6.16e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ABCG5—atherosclerosis	1.32e-05	6.13e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.31e-05	6.09e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.31e-05	6.09e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—LPL—atherosclerosis	1.3e-05	6.06e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PDGFB—atherosclerosis	1.3e-05	6.05e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GSTM1—atherosclerosis	1.29e-05	5.99e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.28e-05	5.98e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—MTHFR—atherosclerosis	1.27e-05	5.94e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LPA—atherosclerosis	1.27e-05	5.92e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GPX1—atherosclerosis	1.27e-05	5.91e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGT—atherosclerosis	1.27e-05	5.9e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—LPL—atherosclerosis	1.26e-05	5.88e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SERPINE1—atherosclerosis	1.26e-05	5.88e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.25e-05	5.85e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.25e-05	5.85e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.25e-05	5.85e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.25e-05	5.85e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARA—atherosclerosis	1.25e-05	5.82e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—atherosclerosis	1.24e-05	5.79e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LEP—atherosclerosis	1.24e-05	5.79e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.24e-05	5.78e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CD36—atherosclerosis	1.24e-05	5.76e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GPX1—atherosclerosis	1.23e-05	5.74e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—BGN—atherosclerosis	1.23e-05	5.73e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CAV1—atherosclerosis	1.23e-05	5.73e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOA1—atherosclerosis	1.23e-05	5.72e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOA5—atherosclerosis	1.22e-05	5.68e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGT—atherosclerosis	1.21e-05	5.64e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOS3—atherosclerosis	1.2e-05	5.61e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CD36—atherosclerosis	1.2e-05	5.59e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPA—atherosclerosis	1.2e-05	5.58e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—atherosclerosis	1.19e-05	5.53e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ESR1—atherosclerosis	1.19e-05	5.52e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CAV1—atherosclerosis	1.18e-05	5.48e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.17e-05	5.46e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOA1—atherosclerosis	1.17e-05	5.46e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—F2—atherosclerosis	1.17e-05	5.46e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—MTHFR—atherosclerosis	1.17e-05	5.45e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.16e-05	5.41e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—BGN—atherosclerosis	1.16e-05	5.4e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARA—atherosclerosis	1.15e-05	5.35e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.15e-05	5.35e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—MTHFR—atherosclerosis	1.14e-05	5.3e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALOX5—atherosclerosis	1.13e-05	5.28e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.12e-05	5.22e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARA—atherosclerosis	1.12e-05	5.2e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGT—atherosclerosis	1.11e-05	5.18e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.1e-05	5.15e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—atherosclerosis	1.09e-05	5.08e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.09e-05	5.08e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CAV1—atherosclerosis	1.08e-05	5.03e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGT—atherosclerosis	1.08e-05	5.03e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOA1—atherosclerosis	1.08e-05	5.02e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MAPK3—atherosclerosis	1.07e-05	5e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CG—atherosclerosis	1.07e-05	4.99e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—atherosclerosis	1.07e-05	4.98e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.07e-05	4.97e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—INS—atherosclerosis	1.06e-05	4.94e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—atherosclerosis	1.06e-05	4.93e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CAV1—atherosclerosis	1.05e-05	4.88e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOA1—atherosclerosis	1.05e-05	4.87e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL2—atherosclerosis	1.04e-05	4.86e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—atherosclerosis	1.03e-05	4.81e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.03e-05	4.81e-05	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—atherosclerosis	1.03e-05	4.81e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IGF1—atherosclerosis	1.03e-05	4.78e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—atherosclerosis	1.02e-05	4.73e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NAMPT—atherosclerosis	1.02e-05	4.73e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—INS—atherosclerosis	1.01e-05	4.72e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LIPC—atherosclerosis	1.01e-05	4.7e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOC3—atherosclerosis	1e-05	4.67e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LDLR—atherosclerosis	9.97e-06	4.65e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CG—atherosclerosis	9.84e-06	4.58e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SERPINE1—atherosclerosis	9.74e-06	4.54e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CETP—atherosclerosis	9.74e-06	4.54e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—FABP4—atherosclerosis	9.71e-06	4.52e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LCAT—atherosclerosis	9.71e-06	4.52e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—atherosclerosis	9.67e-06	4.5e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NAMPT—atherosclerosis	9.57e-06	4.46e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKB1—atherosclerosis	9.56e-06	4.46e-05	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	9.56e-06	4.45e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CG—atherosclerosis	9.55e-06	4.45e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA4—atherosclerosis	9.53e-06	4.44e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LIPC—atherosclerosis	9.51e-06	4.43e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—atherosclerosis	9.49e-06	4.42e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOC3—atherosclerosis	9.45e-06	4.4e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK8—atherosclerosis	9.4e-06	4.38e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LDLR—atherosclerosis	9.39e-06	4.38e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—atherosclerosis	9.38e-06	4.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	9.36e-06	4.36e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SCARB1—atherosclerosis	9.32e-06	4.34e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—INS—atherosclerosis	9.31e-06	4.34e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOS3—atherosclerosis	9.3e-06	4.33e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—atherosclerosis	9.29e-06	4.33e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—atherosclerosis	9.22e-06	4.29e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CETP—atherosclerosis	9.18e-06	4.28e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—INS—atherosclerosis	9.04e-06	4.21e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NOS3—atherosclerosis	8.89e-06	4.14e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMGCR—atherosclerosis	8.81e-06	4.1e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.79e-06	4.09e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—atherosclerosis	8.68e-06	4.04e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.66e-06	4.03e-05	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	8.63e-06	4.02e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—atherosclerosis	8.59e-06	4e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—atherosclerosis	8.54e-06	3.98e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMGCR—atherosclerosis	8.3e-06	3.87e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—atherosclerosis	8.29e-06	3.86e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	8.25e-06	3.84e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK3—atherosclerosis	8.21e-06	3.83e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.2e-06	3.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.2e-06	3.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.2e-06	3.82e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA2—atherosclerosis	8.2e-06	3.82e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NOS3—atherosclerosis	8.17e-06	3.8e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—atherosclerosis	8.13e-06	3.79e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.1e-06	3.78e-05	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	7.97e-06	3.71e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—atherosclerosis	7.97e-06	3.71e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NOS3—atherosclerosis	7.93e-06	3.69e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ABCA1—atherosclerosis	7.85e-06	3.66e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	7.85e-06	3.66e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPA—atherosclerosis	7.83e-06	3.65e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—BGN—atherosclerosis	7.58e-06	3.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA5—atherosclerosis	7.5e-06	3.5e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—atherosclerosis	7.47e-06	3.48e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	7.46e-06	3.48e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ABCA1—atherosclerosis	7.4e-06	3.45e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	7.38e-06	3.44e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	7.26e-06	3.38e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—atherosclerosis	7.25e-06	3.38e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	7.24e-06	3.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.22e-06	3.37e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.98e-06	3.25e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—HMOX1—atherosclerosis	6.73e-06	3.14e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	6.7e-06	3.12e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	6.64e-06	3.09e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOB—atherosclerosis	6.45e-06	3.01e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.35e-06	2.96e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	6.34e-06	2.95e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GSTM1—atherosclerosis	6.27e-06	2.92e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.26e-06	2.92e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.22e-06	2.9e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.18e-06	2.88e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LPL—atherosclerosis	6.16e-06	2.87e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	6.15e-06	2.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.14e-06	2.86e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOB—atherosclerosis	6.08e-06	2.83e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GPX1—atherosclerosis	6.01e-06	2.8e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—atherosclerosis	6e-06	2.8e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CETP—atherosclerosis	6e-06	2.8e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.91e-06	2.76e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CD36—atherosclerosis	5.85e-06	2.73e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPL—atherosclerosis	5.8e-06	2.7e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.75e-06	2.68e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GPX1—atherosclerosis	5.66e-06	2.64e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—MTHFR—atherosclerosis	5.55e-06	2.58e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—atherosclerosis	5.54e-06	2.58e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CD36—atherosclerosis	5.51e-06	2.57e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARA—atherosclerosis	5.44e-06	2.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.43e-06	2.53e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGT—atherosclerosis	5.27e-06	2.45e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.23e-06	2.43e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—atherosclerosis	5.16e-06	2.41e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARA—atherosclerosis	5.13e-06	2.39e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CAV1—atherosclerosis	5.12e-06	2.38e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOA1—atherosclerosis	5.1e-06	2.38e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGT—atherosclerosis	4.97e-06	2.31e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—atherosclerosis	4.86e-06	2.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.84e-06	2.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CAV1—atherosclerosis	4.82e-06	2.25e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOA1—atherosclerosis	4.81e-06	2.24e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.66e-06	2.17e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—atherosclerosis	4.64e-06	2.16e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—atherosclerosis	4.5e-06	2.1e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—INS—atherosclerosis	4.41e-06	2.05e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.39e-06	2.05e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	4.28e-06	1.99e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—atherosclerosis	4.24e-06	1.97e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—INS—atherosclerosis	4.16e-06	1.94e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.15e-06	1.93e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—atherosclerosis	4.08e-06	1.9e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—atherosclerosis	4.04e-06	1.88e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOB—atherosclerosis	3.97e-06	1.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NOS3—atherosclerosis	3.87e-06	1.8e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.87e-06	1.8e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—atherosclerosis	3.81e-06	1.78e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPL—atherosclerosis	3.79e-06	1.77e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—atherosclerosis	3.75e-06	1.75e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GPX1—atherosclerosis	3.7e-06	1.72e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.64e-06	1.7e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—atherosclerosis	3.64e-06	1.7e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CD36—atherosclerosis	3.61e-06	1.68e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—atherosclerosis	3.54e-06	1.65e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.42e-06	1.59e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.35e-06	1.56e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.33e-06	1.55e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGT—atherosclerosis	3.25e-06	1.51e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—atherosclerosis	3.18e-06	1.48e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.15e-06	1.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.14e-06	1.47e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.87e-06	1.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.77e-06	1.29e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—INS—atherosclerosis	2.72e-06	1.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—atherosclerosis	2.49e-06	1.16e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.38e-06	1.11e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.18e-06	1.02e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—atherosclerosis	1.78e-06	8.28e-06	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.68e-06	7.81e-06	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.1e-06	5.1e-06	CbGpPWpGaD
